Member-only story

A Rare Win For Vitamin D Supplementation: Multiple Sclerosis

Randomized trials of Vitamin D supplementation almost always fail. Not this time.

F. Perry Wilson, MD
7 min readMar 10, 2025

Study after study, across diseases from Alzheimer’s to Zika virus, have shown that low vitamin D levels are risk factors for bad outcomes. Seriously, I challenge you to find a disease state where there isn’t at least some data suggesting worse outcomes among people with vitamin D deficiency.

And yet, when the inevitable randomized trial of Vitamin D supplementation comes around, you get… nothing. It’s become a bit of a running joke on this blog — the compelling observational data shut down by the definitive randomized trial.

So we have good data that low levels are associated with various problems, but a failure to show that correcting those levels makes a difference. The implication is simple: it’s the classic case of correlation vs. causation. Low vitamin D levels are simply correlated with bad outcomes, they don’t cause bad outcomes. It’s not actually the Vitamin D that is causing the problem — people who are sick for other reasons just happen to have low Vitamin D. I actually give a…

--

--

F. Perry Wilson, MD
F. Perry Wilson, MD

Written by F. Perry Wilson, MD

Medicine, science, statistics. Associate Professor of Medicine and Public Health at Yale. Host of "Impact Factor" on Medscape.com.

Responses (24)